281 related articles for article (PubMed ID: 25738956)
21. Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India.
Swaminathan S; Paramasivan CN; Ponnuraja C; Iliayas S; Rajasekaran S; Narayanan PR
Int J Tuberc Lung Dis; 2005 Aug; 9(8):896-900. PubMed ID: 16104637
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
[TBL] [Abstract][Full Text] [Related]
23. Initial drug resistance pattern among pulmonary tuberculosis patients.
Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
[TBL] [Abstract][Full Text] [Related]
24. Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.
Sagar T; Singh NP; Kashyap B; Kaur IR
J Postgrad Med; 2013; 59(3):173-6. PubMed ID: 24029192
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
26. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India.
Maurya AK; Kant S; Nag VL; Kushwaha RA; Dhole TN
J Postgrad Med; 2012; 58(3):185-9. PubMed ID: 23023350
[TBL] [Abstract][Full Text] [Related]
27. Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.
Chien JY; Chien ST; Chiu WY; Yu CJ; Hsueh PR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4708-16. PubMed ID: 27216062
[TBL] [Abstract][Full Text] [Related]
28. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
Kumar P; Kumar P; Balooni V; Singh S
Int J Tuberc Lung Dis; 2015 Apr; 19(4):434-9. PubMed ID: 25859999
[TBL] [Abstract][Full Text] [Related]
29. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A
Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855
[TBL] [Abstract][Full Text] [Related]
30. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
[TBL] [Abstract][Full Text] [Related]
31. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
[TBL] [Abstract][Full Text] [Related]
32. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
Mamatha HG; Shanthi V
J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
[TBL] [Abstract][Full Text] [Related]
33. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
34. The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
Ardizzoni E; Mulders W; Kotrikadze T; Aspindzelashvili R; Goginashvili L; Pangtey H; Varaine F; Bastard M; Rigouts L; de Jong BC
Int J Tuberc Lung Dis; 2015 Dec; 19(12):1547-52. PubMed ID: 26614200
[TBL] [Abstract][Full Text] [Related]
35. Resistance pattern in drug-resistant pulmonary tuberculosis.
Nagaraja C; Shashibhushan BL; Sagar C; Asif M; Manjunath PH
J Postgrad Med; 2011; 57(3):181-3. PubMed ID: 21941053
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
[TBL] [Abstract][Full Text] [Related]
37. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
[TBL] [Abstract][Full Text] [Related]
38. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
39. Detection of multidrug-resistant tuberculosis using MGIT™(TM) and MAS-PCR in Tripura, India.
Majumdar T; Bhattacharya S; Barman D; Bhoumik P; Bir R
Int J Tuberc Lung Dis; 2016 Feb; 20(2):166-9. PubMed ID: 26792467
[TBL] [Abstract][Full Text] [Related]
40. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
